T1	intervention 206 215	denosumab
T2	control 223 243	zoledronic acid (ZA)
T3	condition 247 251	pain
T4	eligibility 255 311	patients with advanced breast cancer and bone metastases
T5	No-of-participants 604 608	2046
T6	outcome 836 849	pain severity
T7	outcome 1110 1162	4-month delay in progression to moderate/severe pain
T8	outcome 1268 1303	time to increased pain interference
T9	outcome 1402 1426	time to pain improvement
T10	outcome 1445 1480	time to decreased pain interference
T11	outcome 1576 1589	analgesic use
